USA • New York Stock Exchange • NYSE:DHR • US2358511028
Overall DHR gets a fundamental rating of 6 out of 10. We evaluated DHR against 57 industry peers in the Life Sciences Tools & Services industry. DHR scores excellent on profitability, but there are some minor concerns on its financial health. DHR is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.33% | ||
| ROE | 6.88% | ||
| ROIC | 5.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.15% | ||
| PM (TTM) | 14.71% | ||
| GM | 59.17% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 3.5 | ||
| Altman-Z | 4.36 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.51 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.66 | ||
| Fwd PE | 25.4 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.97 | ||
| EV/EBITDA | 23.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
215.75
-3.78 (-1.72%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.66 | ||
| Fwd PE | 25.4 | ||
| P/S | 6.2 | ||
| P/FCF | 28.97 | ||
| P/OCF | 23.75 | ||
| P/B | 2.9 | ||
| P/tB | N/A | ||
| EV/EBITDA | 23.61 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.33% | ||
| ROE | 6.88% | ||
| ROCE | 6.14% | ||
| ROIC | 5.19% | ||
| ROICexc | 5.52% | ||
| ROICexgc | 35.89% | ||
| OM | 19.15% | ||
| PM (TTM) | 14.71% | ||
| GM | 59.17% | ||
| FCFM | 21.41% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 3.5 | ||
| Debt/EBITDA | 2.57 | ||
| Cap/Depr | 47.24% | ||
| Cap/Sales | 4.71% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 89.71% | ||
| Profit Quality | 145.54% | ||
| Current Ratio | 1.87 | ||
| Quick Ratio | 1.51 | ||
| Altman-Z | 4.36 |
ChartMill assigns a fundamental rating of 6 / 10 to DHR.
ChartMill assigns a valuation rating of 4 / 10 to DANAHER CORP (DHR). This can be considered as Fairly Valued.
DANAHER CORP (DHR) has a profitability rating of 7 / 10.
The Earnings per Share (EPS) of DANAHER CORP (DHR) is expected to grow by 8.89% in the next year.
The dividend rating of DANAHER CORP (DHR) is 6 / 10 and the dividend payout ratio is 24.29%.